Roche: The Hanover specialty growth to rebound after moderating to 3.4% in Q3

The Hanover’s CEO has expressed confidence that growth in his company’s specialty business will rebound in the fourth quarter after moderating in Q3 because of profitability improvement initiatives in its programs segment.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@wbmediagroup.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com